1. Home
  2. CAN vs ABEO Comparison

CAN vs ABEO Comparison

Compare CAN & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAN
  • ABEO
  • Stock Information
  • Founded
  • CAN 2013
  • ABEO 1974
  • Country
  • CAN Singapore
  • ABEO United States
  • Employees
  • CAN N/A
  • ABEO N/A
  • Industry
  • CAN Semiconductors
  • ABEO Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAN Technology
  • ABEO Health Care
  • Exchange
  • CAN Nasdaq
  • ABEO Nasdaq
  • Market Cap
  • CAN 330.5M
  • ABEO 350.2M
  • IPO Year
  • CAN 2019
  • ABEO 1980
  • Fundamental
  • Price
  • CAN $0.81
  • ABEO $5.73
  • Analyst Decision
  • CAN Strong Buy
  • ABEO Strong Buy
  • Analyst Count
  • CAN 6
  • ABEO 6
  • Target Price
  • CAN $2.50
  • ABEO $18.17
  • AVG Volume (30 Days)
  • CAN 28.0M
  • ABEO 705.7K
  • Earning Date
  • CAN 08-14-2025
  • ABEO 11-13-2025
  • Dividend Yield
  • CAN N/A
  • ABEO N/A
  • EPS Growth
  • CAN N/A
  • ABEO N/A
  • EPS
  • CAN N/A
  • ABEO 0.99
  • Revenue
  • CAN $345,360,000.00
  • ABEO $400,000.00
  • Revenue This Year
  • CAN $90.25
  • ABEO N/A
  • Revenue Next Year
  • CAN $42.94
  • ABEO $324.71
  • P/E Ratio
  • CAN N/A
  • ABEO $6.50
  • Revenue Growth
  • CAN 82.40
  • ABEO N/A
  • 52 Week Low
  • CAN $0.53
  • ABEO $3.93
  • 52 Week High
  • CAN $3.27
  • ABEO $7.54
  • Technical
  • Relative Strength Index (RSI)
  • CAN 60.04
  • ABEO 31.80
  • Support Level
  • CAN $0.68
  • ABEO $6.53
  • Resistance Level
  • CAN $0.80
  • ABEO $6.95
  • Average True Range (ATR)
  • CAN 0.04
  • ABEO 0.29
  • MACD
  • CAN 0.01
  • ABEO -0.12
  • Stochastic Oscillator
  • CAN 77.96
  • ABEO 0.36

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: